Patents by Inventor Charles A. Baker

Charles A. Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERCHANGEABLE IMAGE DISPLAY SYSTEM AND METHOD TO CREATE
    Publication number: 20160135620
    Abstract: An interchangeable image display system includes a rigid hard backboard including a backboard front side coated with a protective finish and including at least one photo area, and a backboard back side opposite the backboard front side; one or more rigid hard photo tiles including a photo tile front including an image infused into metal; and a photo tile back; two or more first polarity magnets fixedly attached to the back board front side in each photo area in a first pattern; and two or more second polarity magnets fixedly attached to each of the photo tiles on the photo tile back in a second pattern the mirror image of the first pattern; the second polarity magnets attracted, and removeably attachable to the first polarity magnets.
    Type: Application
    Filed: November 18, 2014
    Publication date: May 19, 2016
    Inventor: Raymond Charles Baker
  • Carbamate derivatives
    Patent number: 9326976
    Abstract: Compounds of formula (I) defined herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: May 3, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Carmelida Capaldi, Charles Baker-Glenn
  • Pyrazole aminopyrimidine derivatives as LRRK2 modulators
    Patent number: 9212173
    Abstract: Pyrazole compounds that are modulators of LRRK2, methods of making the compounds, and methods for using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: December 15, 2015
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Daniel Jon Burdick, Bryan K. Chan, Mark Chambers, Huifen Chen, Anthony Estrada, Zachary Kevin Sweeney
  • Bicyclic pyrazole LRRK2 small molecule inhibitors
    Patent number: 9212186
    Abstract: Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3 and A are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: December 15, 2015
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Bryan K. Chan, Jennafer Dotson, Anthony Estrada, Timothy Heffron, Joseph Lyssikatos, Zachary Sweeney
  • AMINOESTER DERIVATIVES
    Publication number: 20150352091
    Abstract: Compounds of formula (I), defined herein, are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 10, 2015
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Elisabetta ARMANI, Gabriele AMARI, Carmelida CAPALDI, Wesley BLACKABY, Ian LINNEY, Hervé VAN DE POËL, Charles BAKER-GLENN, Naimisha TRIVEDI
  • CARBAMATE DERIVATIVES
    Publication number: 20150352090
    Abstract: Compounds of formula (I) defined herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 10, 2015
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Elisabetta ARMANI, Gabriele Amari, Carmelida Capaldi, Charles Baker-Glenn
  • SYSTEMS AND METHODS FOR CHECKING MODEL PORTFOLIOS FOR ACTIVELY MANAGED FUNDS
    Publication number: 20150348194
    Abstract: Embodiments include systems and methods for evaluating the integrity of a model portfolio designed to have substantially the same values, returns, or risk characteristics as a financial instrument. Embodiments include operating a first computer to perform a statistical comparison between said model portfolio and the financial instrument, wherein said statistical comparison compares at least one of the periodic values, returns, and risk characteristics of the model portfolio and the financial instrument over some period of time. The results of the statistical comparison are periodically published throughout a trading day for use by a trader to at least one (i) price and (ii) hedge an investment in the financial instrument. According to embodiments, the model portfolio does not reveal the holdings of a reference asset for the financial instrument.
    Type: Application
    Filed: August 10, 2015
    Publication date: December 3, 2015
    Inventors: Clifford J. Weber, Scott Ebner, Charles A. Baker, Bonnie Arculli
  • SYSTEMS AND METHODS FOR TRADING ACTIVELY MANAGED FUNDS
    Publication number: 20150348195
    Abstract: Embodiments include systems and methods for evaluating the integrity of a model portfolio designed to have substantially the same values, returns, or risk characteristics as a financial instrument. Embodiments include operating a first computer to perform a statistical comparison between said model portfolio and the financial instrument, wherein said statistical comparison compares at least one of the periodic values, returns, and risk characteristics of the model portfolio and the financial instrument over some period of time. The results of the statistical comparison are periodically published throughout a trading day for use by a trader to at least one (i) price and (ii) hedge an investment in the financial instrument. According to embodiments, the model portfolio does not reveal the holdings of a reference asset for the financial instrument.
    Type: Application
    Filed: August 10, 2015
    Publication date: December 3, 2015
    Inventors: Clifford J. Weber, Carol Alexander, Jason Macqueen, Charles A. Baker, Gary L. Gastineau, Terry Norman
  • Compounds
    Patent number: 9199980
    Abstract: Compounds of formula (I) described herein are inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: December 1, 2015
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Mauro Riccaboni, Andrea Rizzi, Charles Baker-Glenn, Wesley Blackaby, Herve′ Van de Poel, Ben Whittaker
  • SYSTEMS AND METHODS FOR CHECKING MODEL PORTFOLIOS FOR ACTIVELY MANAGED FUNDS
    Publication number: 20150332406
    Abstract: Embodiments include systems and methods for evaluating the integrity of a model portfolio designed to have substantially the same values, returns, or risk characteristics as a financial instrument. Embodiments include operating a first computer to perform a statistical comparison between said model portfolio and the financial instrument, wherein said statistical comparison compares at least one of the periodic values, returns, and risk characteristics of the model portfolio and the financial instrument over some period of time. The results of the statistical comparison are periodically published throughout a trading day for use by a trader to at least one (i) price and (ii) hedge an investment in the financial instrument. According to embodiments, the model portfolio does not reveal the holdings of a reference asset for the financial instrument.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 19, 2015
    Inventors: Clifford J. Weber, Scott Ebner, Charles A. Baker, Bonnie Arculli
  • SYSTEMS AND METHODS FOR TRADING ACTIVELY MANAGED FUNDS
    Publication number: 20150310555
    Abstract: The invention provides systems and methods for intra-day trading of actively managed exchange traded funds (AMETFs). The invention provides creation and redemption structures for AMETF shares that allow arbitrage, intra-day value estimations for AMETF shares, and hedging portfolios for hedging risks associated with trading AMETF shares, all without requiring disclosure of the specific assets underlying the AMETF.
    Type: Application
    Filed: July 1, 2015
    Publication date: October 29, 2015
    Inventors: Clifford J. Weber, Carol Alexander, Jason Macqueen, Charles A. Baker, Gary L. Gastineau, Terry Norman
  • Inhibitors of PDE4 enzyme and antagonists of muscarinic M3 receptor
    Patent number: 9169245
    Abstract: Compounds of formula (I) described herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: October 27, 2015
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Mauro Riccaboni, Charles Baker-Glenn
  • Aminopyrimidine derivatives as LRRK2 modulators
    Patent number: 9145402
    Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: September 29, 2015
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Mark Chambers, Bryan K. Chan, Anthony Estrada, Daniel Shore, Zachary Kevin Sweeney, Huifen Chen
  • Benzhydryl derivatives
    Patent number: 9145409
    Abstract: Compounds having a benzhydryl structure represented by formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for treating diseases of the respiratory tract.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: September 29, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A
    Inventors: Gabriele Amari, Elisabetta Armani, Carmelida Capaldi, Renato De Fanti, Mauro Riccaboni, Charles Baker-Glenn, Hervé Van De Poël
  • Heteroaryl derivatives
    Patent number: 9133185
    Abstract: Compounds of formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: September 15, 2015
    Assignee: Chiesi Farmaceutici S.p.A
    Inventors: Gabriele Amari, Elisabetta Armani, Eleonora Ghidini, Charles Baker-Glenn, Hervé Van De Poël, Ben Whittaker
  • Compounds
    Patent number: 9090606
    Abstract: Compounds of formula (I) defined herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract characterized by airway obstruction.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: July 28, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Mauro Riccaboni, Charles Baker-Glenn
  • HETEROARYL DERIVATIVES
    Publication number: 20150158858
    Abstract: Compounds of formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
    Type: Application
    Filed: December 4, 2014
    Publication date: June 11, 2015
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Gabriele AMARI, Elisabetta ARMANI, Eleonora GHIDINI, Charles BAKER-GLENN, Hervé VAN DE POËL, Ben WHITTAKER
  • BENZHYDRYL DERIVATIVES
    Publication number: 20150158857
    Abstract: Compounds having a benzhydryl structure represented by formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for treating diseases of the respiratory tract.
    Type: Application
    Filed: December 4, 2014
    Publication date: June 11, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Gabriele AMARI, Elisabetta Armani, Carmelida Capaldi, Renato De Fanti, Mauro Riccaboni, Charles Baker-Glenn, Hervé Van De Poël
  • Composite materials, articles of manufacture produced therefrom, and methods for their manufacture
    Patent number: 9045369
    Abstract: The invention is directed to a plastic fiber article of manufacture having composite-like high strength characteristics. The article of manufacture can be in the form of a panel or board. The panel or board is constructed from low cost fiber materials, industrial grade or high thermoplastic, and other additives to protect the board or panel from ultraviolet light, fugii growth, excessive heat, fire, insect infestation, and/or weathering. The plastic fiber panel or board may be textured and colored to resemble natural wood such as cedar, walnut, or oak. The plastic fiber panel or board is stronger more durable and may be cheaper than natural wood alternative panels or boards.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: June 2, 2015
    Assignee: Elk Composite Building Products, Inc.
    Inventor: Charles Baker
  • 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate(SIP)receptors
    Patent number: 9029405
    Abstract: The present invention provides compounds of Formula (I), as selective S1P1 inhibitors, as well as their use for treating multiple sclerosis and other diseases.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: May 12, 2015
    Assignee: Merck Serono S.A.
    Inventors: Agnes Bombrun, Anna Quattropani, Jerome Gonzalez, Jerome Dorbais, Chris Knight, Charles Baker-Glenn